Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FemDx Medsystems is an active, Silicon Valley–based women's health company focused on minimally invasive diagnostics for gynecological conditions. Its flagship FalloView device, cleared by the FDA, is the smallest disposable CMOS endoscope designed for direct visualization of the fallopian tubes and uterine cavity. A first-in-human study in early 2025 demonstrated successful, accurate visualization, with physicians reporting satisfaction in device performance. The company is expanding clinical validation and preparing for broader commercial launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FemDx Medsystems.